000 01221 a2200325 4500
005 20250518021713.0
264 0 _c20201026
008 202010s 0 0 eng d
022 _a1557-9042
024 7 _a10.1089/neu.2018.5999
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFarr, Susan A
245 0 0 _aInhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury.
_h[electronic resource]
260 _bJournal of neurotrauma
_c06 2019
300 _a1869-1875 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aBrain Injuries, Traumatic
_xcomplications
650 0 4 _aCognitive Dysfunction
_xenzymology
650 0 4 _aGlycogen Synthase Kinase 3 beta
_xantagonists & inhibitors
650 0 4 _aMaze Learning
_xdrug effects
650 0 4 _aMice
650 0 4 _aOligonucleotides, Antisense
_xpharmacology
700 1 _aNiehoff, Michael L
700 1 _aKumar, Vijaya B
700 1 _aRoby, Deborah A
700 1 _aMorley, John E
773 0 _tJournal of neurotrauma
_gvol. 36
_gno. 11
_gp. 1869-1875
856 4 0 _uhttps://doi.org/10.1089/neu.2018.5999
_zAvailable from publisher's website
999 _c29314198
_d29314198